日本醫藥第三方物流市場報告（按服務、溫度控制和地區分類，2026-2034年）

Japan Pharmaceutical 3PL Market Report by Service, Temperature Control, and Region 2026-2034

出版日期: 2026年01月01日 | 出版商:

IMARC | 英文 118 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2025年，日本醫藥第三方物流市場規模達65億美元。展望未來， IMARC Group預計到2034年，該市場規模將達到158億美元，2026年至2034年間的複合年成長率（CAGR）為10.35%。製藥公司日益專注於藥物研發等核心競爭力，而無需受制於複雜的經銷和合規要求，是推動市場成長的主要因素。

本報告解答的關鍵問題：

日本醫藥第三方物流市場目前表現如何？未來幾年又將如何發展？
新冠疫情對日本醫藥第三方物流市場產生了哪些影響？
日本醫藥第三方物流市場依服務類型分類的組成是怎樣的？
日本醫藥第三方物流市場依溫度控制分類的組成是怎樣的？
日本醫藥第三方物流市場價值鏈的各個階段有哪些？
日本醫藥第三方物流的關鍵促進因素與挑戰是什麼？
日本醫藥第三方物流市場的結構是怎麼樣的？主要參與者有哪些？
日本醫藥第三方物流市場的競爭程度如何？

Japan pharmaceutical 3PL market size reached USD 6.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 15.8 Billion by 2034, exhibiting a growth rate (CAGR) of 10.35% during 2026-2034. The increasing focus of pharmaceutical companies on their core competencies, like drug development and research, without being encumbered by the intricate demands of distribution and compliance, is primarily driving the market growth.

Third-party logistics (3PL) in the pharmaceuticals sector plays a pivotal role in optimizing the supply chain for drug manufacturers and distributors. Pharmaceutical 3PL providers offer specialized logistics services, ensuring that medications are stored, handled, and transported under stringent regulatory standards, guaranteeing their efficacy and safety. Given the critical nature of pharmaceuticals and their direct impact on patient health, there's an inherent need for precision, timeliness, and compliance within this logistical framework. Today, as the pharmaceutical industry grapples with a globalized market, rising demand, and complex regulatory environments, these 3PL providers become instrumental in navigating these challenges. By integrating advanced technologies, real-time tracking, and compliance management, pharmaceutical 3PLs offer a seamless bridge between manufacturers and end-users, ensuring that lifesaving medications reach their destinations promptly and in optimal condition.

Japan Pharmaceutical 3PL Market Trends:

The Japan pharmaceutical 3PL market is characterized by the nation's healthcare supply chain, epitomizing efficiency, precision, and compliance. One of the primary drivers is the complex regulatory environment surrounding pharmaceuticals. With stringent guidelines on storage, transportation, and distribution, many pharma companies are opting to outsource these logistics challenges to 3PL providers equipped with specialized knowledge and infrastructure. Technological integration is another trend shaping the market. The rise of IoT devices, AI-driven analytics, and blockchain ensures real-time monitoring, enhanced security, and transparent traceability throughout the drug supply chain. This not only improves efficiency but also minimizes the risk of counterfeits or compliance breaches. Furthermore, with Japan's geographical intricacies and the need for last-mile delivery solutions, especially to its aging rural population, 3PL providers are innovating to ensure that medications reach even the most remote areas. Lastly, the ongoing global health challenges have underscored the importance of a robust and agile supply chain. The pandemic-induced disruptions have made pharmaceutical companies more reliant on 3PL partners to navigate uncertainties and ensure continuity of supply. In essence, the combination of regulatory demands, technological advancements, demographic challenges, and health scenarios are projected to propel the Japan pharmaceutical 3PL market for significant growth over the forecasted period.

Japan Pharmaceutical 3PL Market Segmentation:

Service Insights:

Domestic Transportation Management
International Transportation Management
Value-added Warehousing and Distribution

Temperature Control Insights:

Controlled/Cold Chain Logistics
Non-controlled/Non-Cold Chain Logistics

Regional Insights:

Kanto Region
Kansai/Kinki Region
Central/ Chubu Region
Kyushu-Okinawa Region
Tohoku Region
Chugoku Region
Hokkaido Region
Shikoku Region
The report has also provided a comprehensive analysis of all the major regional markets, which include Kanto Region, Kansai/Kinki Region, Central/ Chubu Region, Kyushu-Okinawa Region, Tohoku Region, Chugoku Region, Hokkaido Region, and Shikoku Region.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the key players include:

DHL
FedEx Corporation
Kerry Logistics Network Limited (SF Express Co. Ltd.)
Kuehne + Nagel
Nippon Express Co. Ltd.
Suzuken Co. Ltd.

Key Questions Answered in This Report:

How has the Japan pharmaceutical 3PL market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan pharmaceutical 3PL market?
What is the breakup of the Japan pharmaceutical 3PL market on the basis of service?
What is the breakup of the Japan pharmaceutical 3PL market on the basis of temperature control?
What are the various stages in the value chain of the Japan pharmaceutical 3PL market?
What are the key driving factors and challenges in the Japan pharmaceutical 3PL?
What is the structure of the Japan pharmaceutical 3PL market and who are the key players?
What is the degree of competition in the Japan pharmaceutical 3PL market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Pharmaceutical 3PL Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Pharmaceutical 3PL Market Landscape

5.1 Historical and Current Market Trends (2020-2025)
5.2 Market Forecast (2026-2034)

6 Japan Pharmaceutical 3PL Market - Breakup by Service

6.1 Domestic Transportation Management
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2020-2025)
- 6.1.3 Market Forecast (2026-2034)
6.2 International Transportation Management
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2020-2025)
- 6.2.3 Market Forecast (2026-2034)
6.3 Value-added Warehousing and Distribution
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2020-2025)
- 6.3.3 Market Forecast (2026-2034)

7 Japan Pharmaceutical 3PL Market - Breakup by Temperature Control

7.1 Controlled/Cold Chain Logistics
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2020-2025)
- 7.1.3 Market Forecast (2026-2034)
7.2 Non-controlled/Non-Cold Chain Logistics
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2020-2025)
- 7.2.3 Market Forecast (2026-2034)

8 Japan Pharmaceutical 3PL Market - Breakup by Region

8.1 Kanto Region
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2020-2025)
- 8.1.3 Market Breakup by Service
- 8.1.4 Market Breakup by Temperature Control
- 8.1.5 Key Players
- 8.1.6 Market Forecast (2026-2034)
8.2 Kansai/Kinki Region
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2020-2025)
- 8.2.3 Market Breakup by Service
- 8.2.4 Market Breakup by Temperature Control
- 8.2.5 Key Players
- 8.2.6 Market Forecast (2026-2034)
8.3 Central/ Chubu Region
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2020-2025)
- 8.3.3 Market Breakup by Service
- 8.3.4 Market Breakup by Temperature Control
- 8.3.5 Key Players
- 8.3.6 Market Forecast (2026-2034)
8.4 Kyushu-Okinawa Region
- 8.4.1 Overview
- 8.4.2 Historical and Current Market Trends (2020-2025)
- 8.4.3 Market Breakup by Service
- 8.4.4 Market Breakup by Temperature Control
- 8.4.5 Key Players
- 8.4.6 Market Forecast (2026-2034)
8.5 Tohoku Region
- 8.5.1 Overview
- 8.5.2 Historical and Current Market Trends (2020-2025)
- 8.5.3 Market Breakup by Service
- 8.5.4 Market Breakup by Temperature Control
- 8.5.5 Key Players
- 8.5.6 Market Forecast (2026-2034)
8.6 Chugoku Region
- 8.6.1 Overview
- 8.6.2 Historical and Current Market Trends (2020-2025)
- 8.6.3 Market Breakup by Service
- 8.6.4 Market Breakup by Temperature Control
- 8.6.5 Key Players
- 8.6.6 Market Forecast (2026-2034)
8.7 Hokkaido Region
- 8.7.1 Overview
- 8.7.2 Historical and Current Market Trends (2020-2025)
- 8.7.3 Market Breakup by Service
- 8.7.4 Market Breakup by Temperature Control
- 8.7.5 Key Players
- 8.7.6 Market Forecast (2026-2034)
8.8 Shikoku Region
- 8.8.1 Overview
- 8.8.2 Historical and Current Market Trends (2020-2025)
- 8.8.3 Market Breakup by Service
- 8.8.4 Market Breakup by Temperature Control
- 8.8.5 Key Players
- 8.8.6 Market Forecast (2026-2034)

9 Japan Pharmaceutical 3PL Market - Competitive Landscape

9.1 Overview
9.2 Market Structure
9.3 Market Player Positioning
9.4 Top Winning Strategies
9.5 Competitive Dashboard
9.6 Company Evaluation Quadrant

10 Profiles of Key Players

10.1 DHL
- 10.1.1 Business Overview
- 10.1.2 Services Offered
- 10.1.3 Business Strategies
- 10.1.4 SWOT Analysis
- 10.1.5 Major News and Events
10.2 FedEx Corporation
- 10.2.1 Business Overview
- 10.2.2 Services Offered
- 10.2.3 Business Strategies
- 10.2.4 SWOT Analysis
- 10.2.5 Major News and Events
10.3 Kerry Logistics Network Limited (SF Express Co. Ltd.)
- 10.3.1 Business Overview
- 10.3.2 Services Offered
- 10.3.3 Business Strategies
- 10.3.4 SWOT Analysis
- 10.3.5 Major News and Events
10.4 Kuehne + Nagel
- 10.4.1 Business Overview
- 10.4.2 Services Offered
- 10.4.3 Business Strategies
- 10.4.4 SWOT Analysis
- 10.4.5 Major News and Events
10.5 Nippon Express Co. Ltd.
- 10.5.1 Business Overview
- 10.5.2 Services Offered
- 10.5.3 Business Strategies
- 10.5.4 SWOT Analysis
- 10.5.5 Major News and Events
10.6 Suzuken Co. Ltd.
- 10.6.1 Business Overview
- 10.6.2 Services Offered
- 10.6.3 Business Strategies
- 10.6.4 SWOT Analysis
- 10.6.5 Major News and Events

11 Japan Pharmaceutical 3PL Market - Industry Analysis

11.1 Drivers, Restraints, and Opportunities
- 11.1.1 Overview
- 11.1.2 Drivers
- 11.1.3 Restraints
- 11.1.4 Opportunities
11.2 Porters Five Forces Analysis
- 11.2.1 Overview
- 11.2.2 Bargaining Power of Buyers
- 11.2.3 Bargaining Power of Suppliers
- 11.2.4 Degree of Competition
- 11.2.5 Threat of New Entrants
- 11.2.6 Threat of Substitutes
11.3 Value Chain Analysis